 |
Below is a compilation of items that might be of interest to you. Take a
look at our favorites, a short biography on Dr. Waxman, a forward Dr. Waxman
wrote for an inspiring book on dealing with cancer and a profile in one of
New York's most popular magazines, and gain a better understanding of our Foundation's work.
 |
International Collaboration News - An Interview with Dr. Zhu Chen
Dr. Zhu Chen and the Shanghai Institute of Hematology (SIH) are
long-established collaborators with the Samuel Waxman Cancer Research
Foundation (SWCRF). Dr. Chen is Co-Principal Investigator and Director of
the SWCRF in China. Presently, he is the Director of the Shanghai Institute
of Hematology at the Rui-Jin Hospital in Shanghai, China. He also serves as
Vice President of the Chinese Academy of Sciences and Director of the Human
Genome Center in Shanghai, China.
Recently, Dr. Chen gave us an overview of his collaborative work with SWCRF
and the important role the Foundation has played in the growth and
development of China's biomedical research programs at SIH. |
 |
Biographies - Endowed Professors
Samuel Waxman is a physician-scientist internationally known for his work on megaloblastic anemias,
cancer chemotherapy pharamacology and differentiation therapy of leukemia, a field he helped invent.
Devoted to bringing patients the best possible treatments along with caring human interaction, he was
named in 1998 a founding member of New York magazine¹s Hall of Fame of New York Physicians - one of the few
doctors in the nation to have combined a busy clinical practice with an unwavering commitment to biomedical
research, as well as an exceptionally active roll in medical education. |
 |
Cancer Combat
by DEAN AND JESSICA KING AND JONATHAN PEARLROTH
Picking a Path to Recovery That Satisfies Your Personality, Your Needs, and Your Desires. |
 |
The Best Doctors In New York
from NEW YORK MAGAZINE
Doctors, nurses, hospital executives, and leading specialists were asked one essential question:
Whom would you send a member of your own family to see? |
|
 |